Scotiabank sees ‘deep worth’ in Sage Therapeutics inventory regardless of research setback By Investing.com
On Wednesday, Scotiabank adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE), decreasing the…
Morgan Stanley sees 20% upside for Hole inventory on bullish earnings outlook By Investing.com
On Thursday, Morgan Stanley adjusted its stance on Hole, Inc. (NYSE: NYSE:)…
